Spedizione gratuita per ordini superiori a 69,99 euro.

Controllare lo stato dell'ordine

Entra a far parte di una comunità di amanti dei libri di tutto il mondo e ottieni numerosi vantaggi. Crea un account gratuito

Spedizione gratuita con Packeta per un prezzo superiore a 69.99 €

Corriere Bartolini 4.49 € Punto Poste 5.49 € Punto Poste 5.49 € Punto Bartolini 3.49 € Corriere DHL 6.99 € Corriere GLS 5.99 € Punto GLS 4.49 €

Contatto

Come acquistare

Aiuto

Il mio account

▸ Vuoto :-(

Spedizione gratuita per ordini superiori a 69,99 euro.

Early Drug Development - Strategies and Routes to First-in-Human Trials

Name: Early Drug Development - Strategies and Routes to First-in-Human Trials
Brand: John Wiley & Sons Inc
SKU: 04881677
Price: 192.59 EUR
Availability: InStock
Author: Cayen
ISBN: 9780470170861

Cayen

Lingua

Inglese

Libro Rigido

Codice Libristo: 04881677

Casa editrice John Wiley & Sons Inc, giugno 2010

The focus of early drug development has been the submission of an Investigational New Drug applicati... Descrizione completa

Codice Libristo: 04881677

471 b

192.59 €

Magazzino esterno Inviamo tra 9-15 giorni

Fino a 30 giorni per il reso

I clienti hanno acquistato anche

NIYOMISMALOSE MEGAN MAXWELL

Libro

10.89 €

Dôchodky 2023 (druhé vydanie) Jozef Mihál

In brossura

31.39 €

Bonne Vie Et Meurtres Fred Kassak

In brossura

11.59 €

Approche pragmatique du discours politique Wolof Ndiasse Diop

In brossura

71.69 €

Die Weine im Gebiet der Mosel und Saar F. W. Koch

In brossura

26.19 €

Der Einzelne im Spannungsfeld von Teleologie und Deontologie in der Rechtsprechung des EuGH Morten Göke

In brossura

118.79 €

Die Ratten von Köln Jutta Doris Peters

Rigido

21.49 €

The focus of early drug development has been the submission of an Investigational New Drug application to regulatory agencies. Early Drug Development: Strategies and Routes to First-in-Human Trials guides drug development organizations in preparing and submitting an Investigational New Drug (IND) application. By explaining the nuts and bolts of preclinical development activities and their interplay in effectively identifying successful clinical candidates, the book helps pharmaceutical scientists determine what types of discovery and preclinical research studies are needed in order to support a submission to regulatory agencies.